CRBU Investors with Losses in Excess of $100K Have Opportunity to Lead Caribou Biosciences, Inc. (NASDAQ: CRBU) Securities Fraud Lawsuit

NEW YORK, Dec. 27, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces that a shareholder has filed a class action on behalf of purchasers of Caribou Biosciences, Inc. (NASDAQ: CRBU) securities between July 14, 2023 and July 17, 2024, both dates inclusive…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.